| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Business Operations | EVP, Biodefense Divison
1 company
Havey Adam is an EVP, Business Operations at Emergent BioSolutions Inc.. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $1.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 27, 2017 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sale+OE | 7,885 | $39.50 | $311,457.50 | -23.2% | |
| Sep 8, 2017 | EBS Emergent Biosolutions Inc. | EVP, Business Operations | Sale+OE | 7,885 | $37.06 | $292,242.54 | -23.2% | |
| Apr 3, 2017 | EBS Emergent Biosolutions Inc. | EVP, Biodefense Divison | Sell | 11,419 | $28.62 | $326,808.35 | -30.5% | |
| Jan 17, 2017 | EBS Emergent Biosolutions Inc. | EVP, Biodefense Divison | Sell | 8,438 | $29.75 | $251,000.97 | -19.7% | |
| Mar 14, 2016 | EBS Emergent Biosolutions Inc. | EVP, Biodefense Divison | Sell | 4,359 | $33.96 | $148,031.64 | -5.4% | |
| Mar 11, 2016 | EBS Emergent Biosolutions Inc. | EVP, Biodefense Divison | Sale+OE | 11,112 | $33.84 | $376,030.08 | -11.1% | |
| Jun 15, 2015 | EBS Emergent Biosolutions Inc. | EVP, Biodefense Divison | Sale+OE | 36,298 | $31.55 | $1,145,052.60 | -24.2% | |
| Jun 1, 2015 | EBS Emergent Biosolutions Inc. | EVP, Biodefense Divison | Buy | 98 | $27.08 | $2,653.84 | +0.2% |